Newsfeeds - Spark Newswire

2 minute read

Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs

Today, 6:16 AM

New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per patient monthly when it launched in 2021.

AMGN

1 minute read

FDA Seeks 10% Increase In Biden’s FY 2024 Budget, Proposes Enhancing Regulatory Authorities

By Vandana Singh

Today, 6:16 AM

The FDA has requested $7.2 billion as part of the president’s fiscal year 2024 budget, $128.2 million of which the…

ABT

2 minute read

FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer ‘Tranq’ Or ”Zombie Drug’

By Vandana Singh

Today, 6:16 AM

The FDA issued an “import alert” about the animal tranquilizer xylazine, also called “tranq,” “tranq dope,” and “zombie drug.” The…

BBH

1 minute read

Stryker, DaVita And These 2 ETFs: CNBC’s ‘Final Trades’

By Priya Nigam

Today, 6:16 AM

On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth,

DVA

5 minute read

Biogen’s 2nd Alzheimer’s Antibody, BeiGene’s Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors

By Shanthi Rexaline

Today, 6:16 AM

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.

BGNE

4 minute read

Mirati Plays Catch-Up With Amgen, Gilead’s 2nd Try With AIDS Drug, Cytokinetics’ Adcom Test And More: Key Nov FDA Decisions For Biotech Investors

By Shanthi Rexaline

Today, 6:16 AM

Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.

AMGN

3 minute read

The 10 Most Shorted ETFs: Which Sectors Saw Short Interest Increase?

By Chris Katje

Today, 6:16 AM

Investors often short stocks to hedge positions against long positions or as a way to bet against a particular company. Benzinga provides a look at the most shorted stocks here.

AGG

6 minute read

Bluebird bio Seeks Back-to-Back Nods, ‘Go’ or ‘No-Go’ For Revance’s Botox Rival, Amylyx’ Twin Hurdles And More: September’s Key PDUFA Catalysts Biotech Investors Must Know

By Shanthi Rexaline

Today, 6:16 AM

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

ACAD

1 minute read

CNBC Fast Money Favorites: AMD, CVS, And One Of The Worst Performers In The S&P 500 Today

By AJ Fabino

Today, 6:16 AM

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

AMD

4 minute read

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

By Shanthi Rexaline

Today, 6:16 AM

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.

ACER